SFX by Ex Libris Inc.

Title:	Identification of ubiquitin ligases required for skeletal muscle atrophy
Source:	Science [0036-8075] Bodine, S C yr:2001

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Lecker, S. "Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression." The FASEB journal 18.1 (2003): 39-51.
description	2.	Yancopoulos, G D D. "Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo." Nature cell biology 3.11 (2001): 1014-9.
description	3.	Glass, David J J. "Skeletal muscle hypertrophy and atrophy signaling pathways." The international journal of biochemistry & cell biology 37.10: 1974-1984.
description	4.	Yancopoulos, D J J. "Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways." Nature cell biology 3.11 (2001): 1009-1013.
description	5.	Gomes, M D D. "Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy." Proceedings of the National Academy of Sciences of the United States of America 98.25 (2001): 14440-5.
description	6.	Glass, David J J. "Signalling pathways that mediate skeletal muscle hypertrophy and atrophy." Nature cell biology 5.2: 87-90.
description	7.	Olson, E N N. "Helix-loop-helix proteins as regulators of muscle-specific transcription." The Journal of biological chemistry 268.2 (1992): 755-758.
description	8.	Hawke, T J J. "Myogenic satellite cells: physiology to molecular biology." Journal of applied physiology 91.2 (2001): 534-51.
description	9.	Sandri, M. "Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy." Cell 117.3 (2004): 399-412.
description	10.	Liu, Z. "Human protein metabolism: its measurement and regulation." American journal of physiology 283.6 (2002): 1105-12.
description	11.	Glass, David J J. "Molecular mechanisms modulating muscle mass." Trends in molecular medicine 9.8 (2003): 344-50.
description	12.	Lecker, S. "Slowing muscle atrophy: putting the brakes on protein breakdown." The Journal of physiology 545.Pt (2002): 729-729.
description	13.	Kraemer, William J J. "Hormonal responses and adaptations to resistance exercise and training." Sports medicine 35.4 (2005): 339-361.
description	14.	Bodine, Sue C C. "mTOR signaling and the molecular adaptation to resistance exercise." Medicine and science in sports and exercise 38.11 (2006): 1950-7.
description	15.	Semsarian, C. "Skeletal muscle hypertrophy is mediated by a Ca2+dependent calcineurin signalling pathway." Nature 400.6744 (1999): 576-81.
description	16.	Cuthbertson, D. "Anabolic signaling deficits underlie amino acid resistance of wasting, aging muscle." The FASEB journal 19.3: 422-4.
description	17.	Childs, T. "Temporal alterations in protein signaling cascades during recovery from muscle atrophy." American journal of physiology. Cell physiology 285.2 (2003): -8.
description	18.	Gygi, C. "Weighing in on ubiquitin: the expanding role of mass-spectrometry-based proteomics." Nature cell biology 7.8 (2005): 750-757.
description	19.	Coletta, Dawn K. "Changes in Pre- and Post-Exercise Gene Expression among Patients with Chronic Kidney Disease and Kidney Transplant Recipients." PLoS One 11.8 (2016).
description	20.	McGann, C. "Mammalian myotube dedifferentiation induced by newt regeneration extract." Proceedings of the National Academy of Sciences of the United States of America 98.24 (2001): 13699-13704.